Clinical Pharmacy and Pharmaceutical Care
Core concepts
This domain tests patient-centred practice: medication history taking, pharmaceutical care plans, identification and resolution of drug-related problems (DRPs), patient counselling, adherence support, and pharmacovigilance (adverse drug reaction reporting, the yellow-card concept, causality assessment such as the Naranjo scale, and the difference between an ADR and an adverse event). Candidates should know the principles of medication reconciliation at transitions of care, dose adjustment in renal and hepatic impairment, therapeutic drug monitoring for narrow-therapeutic-index drugs (digoxin, lithium, vancomycin, phenytoin), and counselling points for inhalers, insulin, anticoagulants and antibiotics. Understand the pharmacist's role in antimicrobial stewardship and in detecting and reporting ADRs.
Traps
Questions often present a scenario where the pharmacist should refer or report rather than dispense, or where a 'drug-related problem' is misidentified as non-adherence when it is actually an adverse effect. Another trap is confusing an ADR (causal link to the drug) with an adverse event (temporal association only). TDM questions test timing (trough levels before the next dose) and the fact that TDM is useful only for drugs with a defined relationship between concentration and effect.
Rule of thumb
For any clinical scenario, follow the pharmaceutical care cycle: assess the patient's medication → identify DRPs → prioritise → intervene → monitor and document. For ADR questions, ask 'is there a plausible causal relationship and a temporal sequence, and does it improve on withdrawal?'
Worked example
A patient on lithium presents with tremor and confusion. The pharmacist should recognise possible lithium toxicity, check the serum lithium level (trough, 12 h post-dose), assess renal function and interacting drugs (NSAIDs, thiazides), and advise dose review or withholding pending clinical assessment - not simply reassure.